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Available online 25 March 2016Long-term weight-loss (WL) interventions reduce insulin serum levels, protect from obesity, and postpone
age-associated diseases. The impact of long-term WL on adipose-derived stromal/progenitor cells (ASCs) is
unknown. We identiﬁed DIRAS3 and IGF-1 as long-termWL target genes up-regulated in ASCs in subcutaneous
white adipose tissue of formerly obese donors (WLDs). We show that DIRAS3 negatively regulates Akt, mTOR
and ERK1/2 signaling in ASCs undergoing adipogenesis and acts as a negative regulator of this pathway and an
activator of autophagy. Studying the IGF-1–DIRAS3 interaction in ASCs of WLDs, we demonstrate that IGF-1,
although strongly up-regulated in these cells, hardly activates Akt, while ERK1/2 and S6K1 phosphorylation is
activated by IGF-1. Overexpression of DIRAS3 in WLD ASCs completely inhibits Akt phosphorylation also in the
presence of IGF-1. Phosphorylation of ERK1/2 and S6K1 is lesser reduced under these conditions. In conclusion,
our key ﬁndings are that DIRAS3 down-regulates Akt–mTOR signaling in ASCs of WLDs. Moreover, DIRAS3 in-
hibits adipogenesis and activates autophagy in these cells.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Weight loss1. Introduction
Long-term weight-loss (WL) interventions, such as prolonged
hypocaloric diets and bariatric surgeries, lead to reduced insulin levels,
improvement in insulin sensitivity and glycemic homeostasis in formerly
obese people and improve glycemic control in individuals with diabetesand Differentiation Research,
Innsbruck, Rennweg 10, 6020
erschke).
. This is an open access article undermellitus type 2 (T2DM) (Klein et al., 2004; Dixon et al., 2012). Although
the underlying mechanisms are not precisely understood, one common
key effect of these interventions is a long-term caloric restriction (CR)
(Klein et al., 2004; Sjöström et al., 2004; Bradley et al., 2012; Knop and
Taylor, 2013). Long-term CR, also referred to as dietary restriction (DR),
deﬁned as lessening caloric intake (typically by about 30% in rodents
and monkeys) without malnutrition is the most robust intervention to
extend health and maximum lifespan in most, but not all, laboratory
animal models (Speakman and Mitchell, 2011; de Cabo et al., 2014). It
is widely accepted that CR protects cells against oxidative damage
(López-Lluch et al., 2008) and induces DNA-repair (López-Otín et al.,
2013) and recycling processes such as autophagy (de Cabo et al.,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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stood. Increasing evidence suggests that reduced growth factor- and
nutrient-responsive protein kinase signaling mediate beneﬁcial
effects of CR. Conserved CR-responses are reduced growth hormone
(GH)/insulin-like growth factor-1 (IGF-1) and insulin signaling
(Bartke et al., 2013; Kenyon, 2010). In mammals, GH produced by
the pituitary gland induces production and secretion of IGF-1 in the
liver, which acts as endocrine regulator. IGF-1 is also produced in pe-
ripheral organs by GH-dependent and -independent pathways,
which acts locally in paracrine or autocrine fashion (Sonntag et al.,
2012; Bartke et al., 2013). The impact of CR on IGF-1 signaling in
the periphery is little understood. Another conserved CR-response
is reduced activity of the nutrient-responsive protein kinase, mecha-
nistic target of rapamycin (mTOR), associated with lifespan exten-
sion in invertebrates and mice (Kapahi et al., 2004; Selman et al.,
2009). mTOR forms a network with insulin/IGF-1 signaling, regulat-
ing a wide range of cellular processes, such as autophagy, growth,
differentiation and metabolism, which are thought to mediate
effects of CR (Laplante and Sabatini, 2012). The mechanisms on
how CR employs the insulin/IGF-1–mTOR signaling network to inﬂu-
ence cellular downstream pathways are the current focus of obesity
and aging research.
Adipose tissue is amain organ implicated in regulation of healthspan
induced by reduced insulin/IGF-1–mTOR signaling (Broughton and
Partridge, 2009). Decreased insulin sensitivity in subcutaneous white
adipose tissue (sWAT) due to an age-related deterioration of sWAT is
a hallmark of aging (Borkan et al., 1983). Long-termCR leads to reduced
adipocyte size and remodeling of body fat composition away from
visceral (v) WAT to sWAT (Huffman and Barzilai, 2010; Speakman
and Mitchell, 2011). Since sWAT has rather beneﬁcial and vWAT detri-
mental effects in aging and obesity this contributes to extension of
healthspan. While sWAT adipocytes seem to be particularly beneﬁcial
for insulin action due to their crucial role in maintaining whole body
glucose homeostasis and lipid metabolism, increasing evidence
suggests that health beneﬁts of CR exceed those directly associated
with weight-loss. Adipocytes arise from adipose-derived stromal/
progenitor cells (ASCs), which constitute a large pool of precursors,
crucial for adipose tissue renewal, homeostasis, expansion and hence
function (Berry et al., 2013; Zwierzina et al., 2015). Upon stimulation by
insulin, glucocorticoids, cAMP inducers, and additional serum com-
ponents ASCs enter a differentiation program, referred to as adipo-
genesis, to acquire their speciﬁc functions as adipocytes (Rosen and
MacDougald, 2006). According to the current model adipogenesis
involves growth arrest, early and terminal differentiation, including
morphological changes, lipid accumulation and the expression of
fat cell speciﬁc genes, such as fatty acid binding protein-4 (FABP4),
perilipin and adipokines. The stages of adipogenesis are orchestrated
by a transcriptional cascade involving the adipogenic key factor nuclear
receptor peroxisome proliferator-activated receptor-γ2 (PPARγ2) and
members of the CCAAT/enhancer-binding protein (C/EBP) family.
The impact of WL on ASCs is unknown. By comparing ASCs from
abdominal sWAT of normal weight (NWD), obese (OD) and long-term
weight-losing formerly obese donors (WLDs) we showed that long-
term WL amongst others reduced the adipogenic activity in these cells
(Mitterberger et al., 2014b). To better understand the impact of long-
termWL on human ASCs, we compared gene expression in awell charac-
terized ASC population (Mitterberger et al., 2012; Zwierzina et al., 2015)
isolated from sWAT of age-matched NWDs, ODs, andWLDs using micro-
array gene expression analysis. Intriguingly, two strongly induced WL
target genes were insulin-like growth factor 1 (IGF-1), the activator of
signaling from the IGF-1-receptor, and GTP-binding RAS-like 3 (DIRAS3)
(Yu et al., 1999), an imprinted tumor suppressor gene. DIRAS3 encodes
a small GTPase which was shown to inhibit signaling through
phosphatidylinositol-3-kinase (PI3K) and Ras/Mitogen-activated
protein kinase (MAPK) in tumor cells (Luo et al., 2003) and induces
a dwarf phenotype in transgenic mice (Xu et al., 2000).2. Material and methods
2.1. Donors
Human sWAT samples were taken from persons undergoing routine
abdominoplasty at the Institute for Plastic and Reconstructive Surgery
(Medical University Innsbruck) (Mitterberger et al., 2010, 2011, 2012,
2014a, 2014b). The patients gave their informed written consent and
had been approved by the ethical committee of Innsbruck Medical
University, Austria, according to the Declaration of Helsinki. All sWAT
samples were obtained from the lower abdomen. Obesity and normal
weight were deﬁned according to the World Health Organization
criteria on the basis of the body mass index (BMI = weight [kg]/height
[m2]). Female donors were divided into three groups according to their
BMI, obese (OD) (BMI ≥ 30 kg/m2), normal weight (NWD) (BMI
19–25 kg/m2), and long-term weight losing initially obese (WLD)
(former BMI ≥ 30 kg/m2 and current BMI ≤ 25 kg/m2). None of the
women had diabetes, liver, renal, or other severe metabolic diseases.
Long-term WL was achieved either by hypocaloric diet or laparoscopic
adjustable gastric banding (LAGB). The detailed WL regimens are
described in Mitterberger et al. (2010). The women were age matched.
The clinical and anthropometric parameters are indicated in Table S1.
2.2. Mouse xenograft studies
Mice were treated in accordance with the guidelines of the
“European Convention for the Protection of Vertebrate Animals used
for Experimental and other Scientiﬁc Purposes” and the Austrian law.
Animal experiments were approved by the ethics committee of the
Austrian Federal Ministry of Science and Research (Application No. Zl.
188809/13). Further details are explained in the supplementary exper-
imental procedure.
2.3. Isolation of ASC from human subcutaneous adipose tissue
ASCs were isolated as described (Mitterberger et al., 2012).
2.4. Cell culture
ASCs were cultivated as described (Mitterberger et al., 2012).
2.5. Adipogenic differentiation
Adipogenic differentiation was conducted as described (Mitterberger
et al., 2012).
2.6. Retroviral gene expression system
See supplementary experimental procedures.
2.7. Laser scanning confocal indirect immunoﬂuorescence microscopy
(IF-CLSM)
IF-CLSM was performed as described (Mitterberger et al., 2012).
2.8. Affymetrix microarray gene expression analysis
See supplementary experimental procedures.
2.9. Quantitative RT-PCR analysis
Expression analysis with q-RT-PCR was performed as described
(Mitterberger et al., 2012). β-actin was used for normalization. Primer
sequences are listed in Table S2.
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Western blot analysiswas performed as described (Mitterberger et al.,
2012). Antibodies used in the study are listed in the supplementary
experimental procedures.
2.11. Flow cytometry analysis
Cells were incubated with Lyso-tracker red (Life Technologies) and
analyzed by using FACS Canto (BD Biosciences). Data was analyzed
employing FlowJo software.
2.12. Multispectral imaging ﬂow cytometry
See supplementary experimental procedures.
2.13. Statistical analysis
Statistical analysis was performed in GraphPad Prism (GraphPad
Software Inc., La Jolla, CA, USA). The signiﬁcance of difference between
means was assessed by Student's t test or analysis of variance (ANOVA).
Error bars are represented as the mean ± SEM.
3. Results
3.1. DIRAS3 expression is up-regulated upon long-termWL in human ASCs
DIRAS3 was one of the WL target genes emerged from a global
gene expression analysis performed on human cs (cell surface)-
DLK1(PREF1)−/cs-CD34+/CD90+/CD105+dim/α-SMA+/CD45−/CD31−
ASCs freshly isolated from sWAT (Mitterberger et al., 2012). Cells from
age and sex matched WLDs (hypocaloric diets and laparoscopic adjust-
able gastric banding (LAGB)), NWDs and ODs (Table 1A) were subjected
to whole genome microarray gene expression analysis (Affymetrix Chip
U133+2.0). Results revealed a 11.88-fold higher expression of DIRAS3
in ASCs of WLDs relative to NWDs and a 2.20-fold higher expression of
DIRAS3 in ASCs fromWLDs relative to ODs (Table 1B). Quantitative real
time PCR (q-RT-PCR) conﬁrmed an up-regulation of DIRAS3 expression
in early passage of ASCs of the WLDs relative to NWDs and ODs
(Fig. 1A) and we observed comparatively higher levels of DIRAS3 protein
in adipose tissue lysates fromWL donors (Fig. 1B). Although serum star-
vation is not an idealmodel for chronic CR or long-termWLwe employed
this approach to analyze how DIRAS3 responds to reduced nutrient/
serum levels in vitro. Cultivating ASCs in conditions of serum/growth
factor starvation led to an up-regulation of DIRAS3 mRNA (Fig. 1C) and
DIRAS3 protein (Fig. 1D), conﬁrming the DIRAS3 induction upon WL
in vivo. We conclude that DIRAS3 is up-regulated upon long-termWL in
human ASCs.Table 1
(A) Characteristics of the 2NWDs, 3 ODs and 3WLDs (2 hypocaloric diets, 1 LAGB) employed in
microarray expression proﬁling inASCs freshly isolated fromage-matchedNWDs, ODs, andWLD
emerged from themRNA screen (Mitterberger et al., unpublished results). Thresholds for ident
ulated through CR (+ vs. NW and OW), 2-fold cut-off. For detailed technical information, see s
A.
Age (years) Procedure B
NWD 31 ± 11 2
WLD 36 ± 9 1× LAGB, 2× diet 2
OD 46 ± 2 3
B.
Gene IGF-1 (fold increas
WLD/NWD 23.59
WLD/OD 4.20
OD/NWD 5.623.2. DIRAS3 negatively regulates Akt–mTOR pathway in human ASCs
DIRAS3 can down-regulate PI3K-Akt–mTOR signaling in cancer cells
by inhibition of PI3K activity (Luo et al., 2003). To assess the role of
DIRAS3 in regulation of the Akt–mTOR pathway in human ASCs, we
knocked down (KD) DIRAS3 using gene speciﬁc shRNAs (Fig. 2A).
DIRAS3 KD was conﬁrmed at protein level in the experimental cell
line U-2OS overexpressing DIRAS3 (Fig. 2B). All further experiments
were conducted in ASCs of WLDs. The effect of DIRAS3 KD was exam-
ined in serum starved ASCs and after serum re-stimulation by analyzing
the phosphorylation of Akt, S6K1 and 4EBP1. Serum starvation of
human ASCs down-modulated Akt and S6K1 phosphorylation (Fig. 2C;
see also S. Fig. 1 comparing proliferating cells to 0 h). This down-
regulation was not observed upon KD of DIRAS3, Akt–mTOR pathway
remained active even in the absence of serum (Fig. 2C, compare lanes
1 and5). Additionally, we observed a signiﬁcant higher phosphorylation
of Akt, S6K1 and 4EBP1 in DIRAS3 KD ASCs after serum stimulation
(Fig. 2C–F). To exclude off-target effects we speciﬁcally KD DIRAS3
using a different shRNA sequence and observed similar effects on Akt–
mTOR pathway activity (S. Fig. 2A–D). Similar effects were observed
using ASCs fromdifferent donors. To corroborate our results, we studied
the regulation of Akt–mTOR pathway in ASCs infected with lentiviruses
overexpressing DIRAS3 (Fig. 2G and H). As expected, Akt–mTOR path-
way down-modulation was observed at early time points upon serum
re-stimulation in DIRAS3 over-expressing ASCs as shown by reduced
phosphorylation of Akt, S6K1 and 4EBP1 (Fig. 2I–L). We conclude that
DIRAS3 negatively regulates Akt–mTOR signaling in human ASCs.
3.3. DIRAS3 negatively regulates adipogenesis
Activated insulin/IGF-1 (Boucher et al., 2010) and mTOR signaling
(Laplante and Sabatini, 2012) stimulate adipogenesis. Since DIRAS3
slows Akt–mTOR signaling and long-term WL reduces adipogenic
differentiation capacity of ASCs in formerly obese humans (Mitterberger
et al., 2014b), we investigatedwhether DIRAS3 impinges on adipogenesis
in ASCs. Induction of adipogenic differentiation by a hormone cocktail led
to a morphological transformation of ASCs to rounded cells during ﬁrst
72 h after induction, which is a hallmark of adipogenesis (S. Fig. 3). Differ-
entiation was conﬁrmed by staining fat droplets within the cells by
Oil-Red-O (S. Fig. 3). Interestingly DIRAS3 mRNA expression was signiﬁ-
cantly up-regulated at early stages of adipogenesis, 6 h post-induction,
while peak of expression was observed after 24 h followed by a gradual
decrease (Fig. 3A). Up-regulation of DIRAS3 expression was dependent
on the adipogenesis program, as only the complete adipogenic cocktail
induced DIRAS3 expression (S. Fig. 4A). The other two members of
DIRAS family, DIRAS1 and DIRAS2, were not markedly up-regulated
during adipogenesis (S. Fig. 4B and C). We monitored the activity of
Akt–mTOR pathway in the course of adipogenesis in human ASCs by
analyzing phosphorylation of Akt and S6K1 (S. Fig. 1). Induction ofthe global gene expression analysis. (B) IGF-1 andDIRAS3mRNA expression based on DNA
s. Note, IGF-1 andDIRAS3 are two selectedCR target genes out of a numberof genes,which
iﬁcation of CR genes: Downregulated through CR (− vs. NW and OW), 50% cut-off. Upreg-
upplementary experimental procedures.
MI [kg/m2] Delta BMI [kg/m2] Duration CR (years)
2 ± 3
2 ± 2 14 ± 3 4 ± 2
2 ± 1
e) DIRAS3 (fold increase)
11.8
2.20
5.43
Fig. 1.DIRAS3 expression is up-regulated upon long-termWL in human ASCs. (A) DIRAS3 expression relative to actinwas analyzed by q-RT-PCR in early passage ASCs derived fromWLDs
(n = 4), NWDs (n = 3) and ODs (n = 3). (B) (left panel) Tissue lysates from different donors were examined for DIRAS3 expression by Western blotting. U-2OS cells overexpressing
DIRAS3 served as input control (OV). Equal protein quantities were loaded on SDS PAGE based on BCA quantiﬁcation. Staining of total protein served as control for equal loading.
(Right panel) Densitometric band intensities of the DIRAS3 Western blot were quantiﬁed using ImageJ. (C) ASCs were cultured for 48 h in 10% FCS or in the absence of serum (Wo
FCS) and relative expression of DIRAS3 mRNA was quantiﬁed by q-RT-PCR normalized to actin. (D) Detection of DIRAS3 protein in lysates from ASCs cultured in medium
supplemented with 2.5% FCS and for four days without serum (starvation) by Western blotting. ASCs infected with a DIRAS3 overexpressing lentivirus (DIRAS3 OV) served as control.
All error bars represent the means ± SEM. p values * = p b 0.05, ** = p b 0.001 and *** = p b .0001. The signiﬁcance of difference between means was assessed by analysis of
variance (ANOVA) (A and B) and Student's t test (C).
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density arrested cells (Fig. 3B). Phosphorylation gradually decreased
to its basal level approximately 6 h post-induction. Next, we tracked
the phosphorylation of Akt and S6K1 in the ﬁrst 72 h after induction of
adipogenesis in DIRAS3 KD ASCs and detected a marked up-regulation
of Akt and S6K1 phosphorylation upon DIRAS3 knockdown (Fig. 3B).
Additionally, down-regulation of DIRAS3 was associated with stronger
differentiation of ASCs as revealed by a signiﬁcantly increased induction
of FABP4, perilipin and adiponectin (Fig. 3C), higher perilipin protein
level (Fig. 3D) and increased lipid accumulation at day 9 post-induction
(Fig. 3E). A homolog of DIRAS3 was not found in mice (Yu et al., 2006).
To study the impact of DIRAS3 on adipogenesis in vivo, we injected
DIRAS3 KD human ASCs and control ASCs committed to adipogenesis
into the posterior sWAT of SCID mice. As shown in Fig. 3F and G, differ-
entiating ASCs were predominantly found in peripheral regions of
the transplants adjacent to mouse sWAT. DIRAS3 KD ASCs showed
increased adipocyte differentiation in mouse sWAT relative to controls
(Fig. 3H), suggesting that DIRAS3 negatively regulates adipogenesis in
sWAT of mammals. In accordance with the pro-adipogenic effect of
the DIRAS3 KD, overexpression of DIRAS3 in ASCs diminished adipo-
genesis as shown by signiﬁcant decrease in mRNA level of FABP4,
perilipin and adiponectin uponDIRAS3 overexpression (Fig. 3I). In addi-
tion, the perilipin protein level and lipid droplets were decreased in
DIRAS3 overexpressing cells at day 9 post-adipogenesis induction
(Fig. 3J andK).We conclude thatDIRAS3negatively regulates adipogen-
esis in human ASCs.
3.4. Regulation of adipogenesis by DIRAS3 is mediated by C/EBP-β and
PPAR-γ2
To better understand the mechanisms on how DIRAS3 regulates
adipogenesis, we analyzed the expression of transcription factors
C/EBP-β, C/EBP-α and PPAR-γ2, which are key regulators of adipogenesis
(Rosen and MacDougald, 2006). DIRAS3 KD led to a signiﬁcant up-
regulation in the expression of all three genes in ASCs undergoing
adipogenic differentiation (Fig. 4A). Translation of the C/EBP-β
mRNA gives rise to three different isoforms, C/EBP-β Full-LAP and
C/EBP-β LAP, which are activating isoforms and C/EBP-β LIP, whichis an inhibitory isoform (Lechner et al., 2013). C/EBP-β induces the
expression of PPAR-γ2 and C/EBP-α, which are the two key regulators
of terminal adipogenesis (Park et al., 2004).We analyzed C/EBP-β protein
levels and observed higher levels of C/EBP-β Full-LAP and -LAP in the ﬁrst
72 h of induction upon DIRAS3 KD (Fig. 4B, left panel), while no marked
difference was detected in C/EBP-β LIP protein level (Fig. 4B, right
panel). Differential migration of CEBP-β Full-LAP and -LAP bands in SDS
PAGE corresponds to differential phosphorylation. Activated extracellular
signal regulated kinase 1/2 (ERK1/2) was shown to phosphorylate T188
residue of C/EBP-β and thus activate the transcription factor (Park
et al., 2004). In accordance, Western blot analysis revealed a marked
up-regulation of ERK1/2 phosphorylation during the ﬁrst 72 h of adipo-
genesis in DIRAS3 KD ASCs (Fig. 4C). The transcription factor Foxo1
negatively controls PPAR-γ2 expression when localized within the
nucleus (Nakae et al., 2003). Foxo1 is negatively regulated by Akt, as
its phosphorylation by active Akt leads to its exclusion from the nucleus
(Brunet et al., 1999). As DIRAS3 KD is associated with an increased
phosphorylation of Akt (Figs. 2C and 3B), we analyzed changes in Foxo1
phosphorylation in ASCs. In fact, DIRAS3 KD led to an up-regulation of
Foxo1 phosphorylation (Fig. 4D) and IF-CLSM showed reduced nuclear
localization of Foxo1 in DIRAS3 KD ASCs relative to controls (Fig. 4E).
This suggests that activated Akt induced by nuclear exclusion of Foxo1
contributes to increased PPAR-γ2 expression upon DIRAS3 KD. Inhibition
of Akt and ERK by speciﬁc chemical inhibitors diminished DIRAS3 KD
mediated up-regulation of adipogenesis, underscoring that active Akt
and ERK1/2 execute positive regulation of adipogenesis via C/EBP-β and
PPAR-γ2 respectively upon DIRAS3 KD (S. Fig. 5A and B).
3.5. DIRAS3 regulates autophagy in human ASCs
Increased autophagy is one conserved CR-response induced by
reduced insulin/IGF-1–mTOR signaling (Laplante and Sabatini, 2012)
and DIRAS3 was shown to induce autophagy in cancer cells (Lu et al.,
2008). To test whether down-regulation of Akt–mTOR signaling by
DIRAS3 stimulates autophagy in human ASCs, we initially conducted
Western blot experiments in DIRAS3 KD and overexpressing cells to
monitor the cleavage of LC3I to LC3II as amarker for increased autophagy
(Klionsky et al., 2012). LC3I and LC3II levels were examined in serum
Fig. 2. Impact of DIRAS3 knock-down (KD) and over-expression (OV) on Akt–mTORpathway in humanASCs. (A) Efﬁciency of RNA interferencemediatedDIRAS3KD inASCswas analyzed
at mRNA level using q-RT-PCR employing actin as reference gene. (B) DIRAS3 KD efﬁcacy at protein level was evaluated by Western blotting. DIRAS3 was overexpressed in the
experimental cell line U-2OS, followed by KD using speciﬁc shRNA expressing lentiviruses. (C) DIRAS3 was KD in ASCs using speciﬁc shRNA, and cells were density arrested and
starved by serum withdrawal for 48 h. Then a cocktail containing 2.5% FCS, insulin, 3-isobutyl-1-methylxanthine, and dexamethasone was added. Cell lysates were harvested at
indicated time points. Phosphorylation of Akt (S473), S6K1 (T389) and 4EBP1 (T37/46) was examined by Western blotting. (D–F) Fold changes in densitometric band intensities,
acquired by ImageJ were compared. Band intensity of shCntrl at time point 0 min was taken as 1. (G) Overexpression of DIRAS3 mRNA normalized to actin and (H) protein in ASCs
infected with lentiviruses expressing DIRAS3 under control of CMV promoter. (I) Following DIRAS3 over-expression, cells were density arrested and starved by serum withdrawal for
48 h. Then a cocktail containing 2.5% FCS, insulin, 3-isobutyl-1-methylxanthine, and dexamethasone was added. Cell lysates were harvested at indicated time points. Phosphorylation
of Akt (S473), S6K1 (T389) and 4EBP1 (T37/46) was examined by Western blotting from cell lysates harvested at indicated time points. (J–L) Fold changes in densitometric band
intensities, acquired by ImageJ were compared. Band intensity of Mock control at time point 0 min was taken as 1. All error bars represent the means ± SEM. p values * = p b 0.05,
** = p b 0.001 and *** = p b .0001. The signiﬁcance of difference between means was assessed by analysis of variance (ANOVA) (D, E, F, J, K and L).
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KD signiﬁcantly reduced LC3I to LC3II conversion in both conditions
(Fig. 5A), while over-expression of DIRAS3 signiﬁcantly enhanced levels
of LC3II cleaved form (Fig. 5B), suggesting a role of DIRAS3 in autophagy
induction. To prove that autophagic activity includes ﬂux through the
entire system, including lysosomes, and the subsequent release of the
degradation products, we analyzed autophagy ﬂux using baﬁlomycinA1, an inhibitor of lysosomal degradation, resulting in accumulation of
LC3II. Under these conditions we found an increased accumulation of
LC3II in DIRAS3 overexpressing ASCs, while in DIRAS3 KD LC3II accumu-
lation was markedly reduced (Fig. 5C). The cysteine protease ATG4 is
necessary for the processing of LC3I to LC3II and DIRAS3 is associated
with ATG4 expression in ovarian cancer cells (Lu et al., 2008). In keeping
with this a signiﬁcant decrease in ATG4 protein level was detected upon
Fig. 3. DIRAS3 is a negative regulator of adipogenesis in human ASCs. (A) DIRAS3 mRNA expression normalized to actin was investigated by q-RT-PCR during the course of adipogenesis
(n= 6). (B) Akt–mTOR pathway activity pattern wasmonitored during the ﬁrst 72 h of adipogenesis upon DIRAS3 KD. Phosphorylation of Akt (S473) and S6K1 (T389) was examined by
Western blotting. (C) ASCs infected with either shCntrl or shDIRAS3 expressing lentiviruses were subjected to adipogenesis and mRNA expression of adipocyte marker genes FABP4,
Perilipin and Adiponectin normalized to actin were analyzed using q-RT-PCR at the indicated time points. (D) Perilipin protein expression was analyzed by western blotting at day 9
post-adipogenesis induction in shCntrl and shDIRAS3 ASCs. (E) Adipocyte differentiation was estimated using Oil-Red-O staining at day 9 post-induction. (F and G) Representative
immunohistochemical staining of xenotransplanted shDIRAS3 SCID mice (F) and shCntrl mice (G) using anti-perilipin antibodies. Region of Interest (ROI) is shown in higher
magniﬁcation. (H) Margin of the transplant from each mice was imaged at 20× magniﬁcation and perilipin positive and negative cells were counted using ImageJ cell counter plugin
and shown as percentage positive cells (n = 6). (I–K) ASCs infected with either Mock or DIRAS3 overexpressing lentiviruses were subjected to adipogenesis and mRNA expression of
adipocyte marker genes normalized to actin was analyzed using q-RT-PCR at the indicated time points (I). Perilipin protein analysis (J) and Oil-Red-O staining (K) were done at day 9
post-induction of adipogenesis. All error bars represent the means ± SEM. p values * = p b 0.05, ** = p b 0.001 and *** = p b .0001. The signiﬁcance of difference between means was
assessed by analysis of variance (ANOVA) (A, C and I) and Student's t test (H).
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Fig. 4.DIRAS3 knock-downmediated enhancement of adipogenesis is orchestrated byup-regulation of C/EBP-β and PPAR-γ2. (A) Relative expression of CEBP-β, PPAR-γ2 andCEBP-αwas
analyzed normalized to actin at different time points during adipogenesis by RT-PCR. (B) CEBP-β protein level during 72 h after adipogenesis induction. For optimal separation of bands, C/
EBP-β Full-LAP and C/EBP-β LAP were analyzed using a 8% PAGE (upper panel) and C/EBP-β LIP using a 12,5% PAGE (lower panel). (C and D) Phosphorylation of ERK1/2 (T282/Y204)
(C) and Foxo-1(S256) (D) was monitored by Western blotting during 72 h of adipogenesis. (E) Localization of Foxo-1 within the cells upon DIRAS3 KD was visualized by IF-CLSM.
Foxo-1 (green), TO-PRO3 for nuclear staining (red), Merge (white, obtained by using a co-localization mask). Co-localization mask was obtained by plotting gray scale pixels in x–y
axis scatter plot, where x-axis represents green channel (Foxo1) and y-axis represents red channel (TO-PRO3). Double positive pixels are represented in co-localization mask as white.
Laser Sharp 2000 software from Zeiss was employed for the image analyses. All error bars represent the means ± SEM. p values * = p b 0.05, ** = p b 0.001 and *** = p b .0001. The
signiﬁcance of difference between means was assessed by analysis of variance (ANOVA) (A).
155A. Ejaz et al. / EBioMedicine 6 (2016) 149–161DIRAS3 KD (Fig. 5D), underscoring that DIRAS3 stimulates autophagy
in ASCs. Moreover, visualization of autophagic punctate employing
GFP-LC3 as marker for autophagosome detection, demonstrated that
knock-down of DIRAS3 in GFP-LC3 expressing ASCs led to a decreased
punctate formation (Fig. 5E). In contrast, DIRAS3 over-expression
enhanced accumulation of punctate spots (Fig. 5F). To quantitate cells
displaying high autophagic puncta we employed image stream multi-
spectral ﬂow cytometry (Klionsky et al., 2012). Human ASCs co-infected
with lentiviruses expressing GFP-LC3 were serum-starved (positive
control) or not starved (negative control) and monitored (S. Fig. 6I). We
deﬁned a cell population having more than 3 puncta as high autophagy
cells. A 15-fold increase in cell number displaying high autophagy upon
starvation was observed when compared to cells incubated in 10% FCS
(non-induced) (Fig. 5G). Next, ASCs were co-infected with lentiviruses
expressing GFP-LC3 and DIRAS3 shRNA or control shRNA. DIRAS3 KD
led to a signiﬁcant decrease in the number of cells displayinghigh autoph-
agy (Fig. 5H and S. Fig. 6J). Another hallmark of autophagy is developmentof acidic vesicular organelles which can be detected by FACS using
lysotracker red staining. Consistent with Western blot data (Fig. 5A–C),
we observed signiﬁcantly lower ﬂuorescence intensity in DIRAS3 KD
ASCs (Fig. 5I) and signiﬁcant higher ﬂuorescence intensity in DIRAS3 OV
ASCs (Fig. 5J), indicating that DIRAS3 level is one of the determinants of
autophagy. Furthermore, we demonstrate regulation of autophagy
related genes upon DIRAS3 KD (S. Fig. 6A–D) and DIRAS3 overexpression
(S. Fig. 6E–H). We conclude that DIRAS3 regulates autophagy in human
ASCs. Having shown that WLDs display an increased DIRAS3 expression
in their ASCs and abdominal sWAT (Fig. 1A, B and Table 1) and that
increased DIRAS3 expression is linked to higher autophagy in ASCs
(Fig. 5A–J), we investigated LC3I/LC3II protein level in the WAT lysates
of the givendonor groups.We found a higher LC3II to LC3I ratio in adipose
tissue lysates from WLDs relative to NWD and OD, conﬁrming
elevated induction of autophagy (Fig. 5K). Together our results
highlight a role of DIRAS3 in autophagy induction upon long-term
WL in humans ASCs.
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157A. Ejaz et al. / EBioMedicine 6 (2016) 149–161Impaired adipogenesis in ATG5 and ATG7 knock-out mice indicates
that autophagy is essential for adipogenesis (Baerga et al., 2009;
Zhang et al., 2009). IGF-1–mTOR signaling plays an important role in
the regulation of both adipogenesis and autophagy; the inhibition of
IGF-1–mTOR pathway induces autophagy but reduces adipogenesis
(Laplante and Sabatini, 2012; this study). To better understand the
interaction between IGF-1–mTOR and autophagy activity in adipogene-
sis, we monitored the conversion of LC3I to LC3II in human ASC during
differentiation. We found a consistent induction level of autophagy in
the course of adipogenesis, demonstrating a general role of autophagy
in this process (S. Fig. 1). However, upon DIRAS3 KD we detected a
decrease in autophagic activity (Fig. 5L) incidental to up-regulated
Akt–mTOR signaling (Fig. 3B) and increased adipogenesis (Fig. 3C–E).
Thus, although autophagy is essential for adipogenesis in ASCs an acti-
vated Akt–mTOR pathway can obviously drive this process at reduced
but sufﬁcient autophagic activity.
3.6. Long-term WL induces IGF-1 expression in human ASCs
AnotherWL target genewhich emerged from our microarray analy-
siswas IGF-1, the activating ligand of the IGF-1 receptor (IGF-1-R). IGF-1
showed a 23.59-fold up-regulation in ASCs ofWLDs versus NWDs and a
4.20-fold higher expression in ASCs from WLDs relative to ODs
(Table 1B). These results were conﬁrmed in early passage ASCs from
WLD, OD and NWD donors by q-RT-PCR (Fig. 6A). The further experi-
ments were conducted in ASCs fromWLDs. Serum-starvation of prolif-
erating ASCs induced IGF-1 mRNA expression (Fig. 6B), supporting our
in vivo observed IGF-1 up-regulation upon WL. Furthermore, we
corroborated that ASCs derived from sWAT secrete IGF-1 in culture
(Fig. 6C). These ﬁndings were intriguing, because reduced IGF-1
serum levels in rodents (Breese et al., 1991; Sonntag et al., 1999) and
reduced insulin/IGF-1 signaling in invertebrates (Kenyon, 2010) are
considered as conserved CR responses but IGF-1 serum levels are not
altered following long-term CR (N1 year) in humans (Fontana et al.,
2008). There is also precedence for IGF-1 up-regulation in peripheral
tissues of animal longevity models, including the fat body of Drosophila
(Broughton and Partridge, 2009). Since IGF-1 stimulates differentiation
of preadipocytes (Boucher et al., 2010; Poulos et al., 2010), its expression
during adipogenesis was investigated in human ASCs. We found a signif-
icant up-regulation of IGF-1 between days 1 and 3 post-induction of
adipogenesis (Fig. 6D). A sharp decrease in the IGF-1 expression was
observed at day 4 after exclusion of IMBX from the medium, suggesting
that the adipogenesis program drives the increase in IGF-1 expression
(Fig. 6D). Concomitant with increased IGF-1 mRNA level, we found
signiﬁcantly increased IGF-1-R expression upon serum starving ASCs
(Fig. 6E) and during adipogenesis (Fig. 6F). The induction of DIRAS3 in
adipogenesis followed a similar time course (Fig. 3A). We also found
that exogenous addition of IGF-1 leads to a slight induction of DIRAS3 in
WLD ASCs (Fig. 6G). This suggests that positive and negative regulators
of IGF-1 signaling are induced during adipogenesis and obviously also in
normal ASCs. In the course of adipogenesis, in pro-adipogenic medium,
both the MAPK (Fig. 4C) and the PI3K–mTOR pathways (Figs. 2C and
3C) are strongly activated and DIRAS3 can inhibit both of them. To betterFig. 5.WL-induced overexpression of DIRAS3 increases autophagy. (A and B) DIRAS3was KD (A
Western blotting at different time points after induction of adipogenesis. (Right panels) Densito
DIRAS3 KD and DIRAS3OV ASCs by starving these cells for 3 h with HBSS in the presence of 4
(D) Western blot analysis of ATG4b expression upon DIRAS3 KD (left panel). Band intensities
LC3 and either shDIRAS3 (E) or DIRAS3 overexpressing lentiviruses (F). Cells were starved for
ASCs were co-infected with GFP-LC3 and shControl or shDIRAS3 lentiviruses. Cells were analyz
a positive control for autophagy induction and a fold change in autophagy high cells was
(H) Number of autophagy high cells in shcontrol settings was taken as 1 and a fold change wa
autophagy in ASCs upon DIRAS3 KD (J) or DIRAS3 OV (K) using Lyso-tracker red dye. (K) WAT
conversion to LC3II (upper panel). Densitometric band intensities were quantiﬁed using Im
during adipogenesis in DIRAS3 KD and control ASCs. All error bars represent the means ±
difference between means was assessed by analysis of variance (ANOVA) (A, B, D and K) and Sunderstand the interaction between IGF-1 and DIRAS3 in ASCs from
WLDs, we studied the biochemical interaction between the two proteins
in regulating Akt, ERK1/2 andmTOR pathway. To do this, we added solely
IGF-1 in concentrations at 0.5 × 10−9 M–2.5 × 10−8 M, which are in the
physiologically range for the stimulation of human preadipocytes (Bäck
and Arnqvist, 2009), toWLD ASCs infected withmock or DIRAS3 overex-
pression lentiviruses. Although IGF-1 is strongly up-regulated in ASCs of
WLDs (Table 1B, Fig. 6A), IGF-1 could hardly induce phosphorylation of
Akt in mock WLD ASCs (Fig. 6H, left panels). Phosphorylation of S6K1
and ERK1/2 was induced by IGF-1 in these cells (Fig. 6H, left panels).
Overexpression of DIRAS3 inWLD ASCs completely inhibited phosphory-
lation of Akt also in the presence of IGF-1 (Fig. 6H, right panels).
Phosphorylation of ERK1/2 was less reduced under these conditions and
S6K1 remained also active to some extent.
4. Discussion
Transgenic mice overexpressing the human DIRAS3 gene show
decreased body size, reduced development in multiple organs and are
proportionally smaller than nontransgenic littermates (Xu et al.,
2000). This phenotype is similar to calorically restricted mice, which
showed reduced insulin and IGF-1 serum levels (Speakman and
Mitchell, 2011). In the present study, we identiﬁed DIRAS3 asWL target
gene up-regulated in ASCs of formerly obese humans upon long-term
WL and demonstrated that DIRAS3 reduces adipogenic differentiation
in these cells. Under pro-adipogenic conditions DIRAS3 strongly
counteracted activation of Akt andmTOR signaling. Moreover, although
IGF-1 expression was up-regulated in the course of adipogenesis
DIRAS3 reduced adipogenic differentiation. Thus, DIRAS3 counteracted
insulin and IGF-1 activity during adipogenesis. Additionally, DIRAS3
decreased adipocyte differentiation product levels (FABP4, perilipin
and adiponectin) in immature adipocytes. These data suggest that
DIRAS3 activity down-modulates adipogenesis and anabolic processes
in sWAT of WLDs. This is in accordance with the previously shown
reduced adipogenic capacity of ASCs explanted from sWAT of WLDs
(long-term restricted by hypocaloric diet or bariatric surgery)
(Mitterberger et al., 2014b). Insulin levels in serum of WLDs are
signiﬁcantly lower than those in serum of ODs and NWDs
(Mitterberger et al., 2010, 2011). Given the importance of insulin as a
potent positive regulator of adipogenesis, it is likely that increased
DIRAS3 levels further add to a reduced adipogenic activity in ASCs of
sWAT of formerly obese donors. Both insulin and IGF-1 can in principle
stimulate adipogenesis in adipose progenitor cells, which express the
highly homologous insulin receptors (IR) and IGF-1 receptors (IGF-1R)
at their surface (Bäck and Arnqvist, 2009; Boucher et al., 2010). While
insulin and IGF-1 bind preferentially to their cognate receptors the two
hormones can induce adipogenesis via activation of both the IR and IGF-
1R in preadipocytes. To clarify the importance of insulin in obesity, WL
and CR it should be noted that insulin serum levels aremore dynamically
regulated than IGF-1 serum levels in both conditions. Moreover, both IR
and IGF-1R are present at adipocytes, with considerably more IR on
these cells, leading to a lipodystrophic phenotype in IR knockouts (KOs)
in adipose (Blüher et al., 2002), while IGF-1R KO in adipose seem) or overexpressed (B) in ASCs. (Left panels) Conversion of LC3I to LC3II wasmonitored by
metric band intensities were quantiﬁed using ImageJ. (C) Autophagy ﬂuxwas evaluated in
00 nM baﬁlomycin A1. Conversion of LC3I to LC3II was monitored by Western blotting.
were quantiﬁed using ImageJ (right panel). (E and F) ASCs were co-infected with GFP-
3 h and LC3 punctate formation was visualized by IF-CLSM. 400× magniﬁcation. (G–H)
ed by image stream multispectral ﬂow cytometer. (G) Serum starved cells were taken as
calculated taking the number of autophagy high cells in the presence of serum as 1.
s calculated upon DIRAS3 KD. (I and J) Lysosomal acidity was monitored as a read-out of
lysates fromWLDs, NWDs and ODs were analyzed by Western blotting to evaluate LC3I
ageJ (lower panel). (L) Conversion of LC3I to LC3II was monitored by Western blotting
SEM. p values * = p b 0.05, ** = p b 0.001 and *** = p b .0001. The signiﬁcance of
tudent's t test (H, I and J).
Fig. 6. Long-termWL induces IGF-1 expression in human ASCs. IGF-1 is up-regulated during adipogenesis and IGF-1-induced Akt–mTOR activation is counteracted by DIRAS3. (A) IGF-1
expressionwas studied by q-RT-PCR inASCs derived fromWLDs (n=4), NWDs (n=3) andODs (n=3)normalized to actin. (B) IGF-1 expressionwas analyzed upon serumstarvation of
ASCs in reference to actin gene. (C) IGF-1 concentration in supernatant (SN) of ASCs derived from sWAT ofWLDs after 3 days of cultivation in basalmedium (containing 10% FCS) relative
to basal medium (containing 10% FCS) was determined by human IGF-1 ELISA kit (Ref: E20, Lot: 120115, Mediagnost, Germany). (D) IGF-1 expression was investigated in the course of
adipogenesis using q-RT-PCR normalized to actin. (E) IGF-1-R expression was analyzed upon serum starvation of ASCs using actin as reference gene. (F) IGF-1R expression normalized to
actinwas investigated in the course of adipogenesis using q-RT-PCR. (G) DIRAS3 expression in ASCs at 6 h after addition of IGF-1was quantiﬁed by q-RT PCR employing actin as reference gene.
(H) ASCs were infectedwithmock or DIRAS3 overexpression lentiviruses. Cells were starved for 48 h followed by addition of increasing concentrations of IGF-1 for 10min. Phosphorylation of
Akt (S473), S6K1 (T389) and ERK1/2 (T282/Y204) was examined by Western blotting. All error bars represent the means ± SEM. p values * = p b 0.05, ** = p b 0.001 and *** = p b .0001
(number of donors = 3). The signiﬁcance of difference between means was assessed by analysis of variance (ANOVA) (A, D and G) and Student's t test (B, C and E).
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induced, reduced insulin serum concentrations count also strongly for
beneﬁcial metabolic effects at the adipocyte level, such as reduced lipid
depots. When the IR (Blüher et al., 2002) or IGF-1R (Klöting et al., 2008)
is inactivated in adipose tissue in mice these pathways can however
at least in part compensate for each other.
Intriguingly, in the present study, we found that in addition to
DIRAS3, IGF-1, the activating ligand of the IGF-1R, was considerably
induced in ASCs from WLDs. We showed however that addition of
IGF-1 to WLD ASCs hardly stimulated Akt phosphorylation. Moreover,
DIRAS3 overexpression completely inhibited Akt phosphorylation also
in the presence of high levels of IGF-1. IGF-1 stimulated ERK1/2
phosphorylation in the WLD ASCs and S6K1 was also phosphorylated
to some extent. In DIRAS3 overexpressing cells ERK1/2 and S6K1 phos-
phorylationwas reduced also in the presence of IGF-1 but both (ERK1/2and S6K1) remained active under these conditions. Our data suggest
that DIRAS3 dominantly down-regulates the IGF-1R–Akt–mTOR branch
inWLD ASCs. Moreover, it is conceivable that the functional interaction
between IGF-1 and DIRAS3 channels the IGF-1 stimulus away from Akt
more to the ERK1/2 branch. A minimum of IGF-1/IGF-1-R signaling is
most likely important to balance down-modulated anabolic processes
along with growth, differentiation and survival of ASCs. In fact, it has
been shown that extreme low IGF-1 signaling is incompatible with life
and supplementation of IGF-1 can ameliorate premature aging in proge-
ria mice with very low levels of IGF-1 (Mariño et al., 2010). Further, in
contrast to laboratory animal models, long-term CR does not reduce
circulating IGF-1 levels and IGF-1:IGFBP-3 ratio in non-obese humans
(Fontana et al., 2008). Similarly, we have shown that total IGF-1
serum levels, free IGF-1 and the molar IGF-1:IGFBP-3 ratio are not
signiﬁcantly lower in WLDs than in ODs (Mitterberger et al., 2011).
159A. Ejaz et al. / EBioMedicine 6 (2016) 149–161Themolar ratio between IGF-1:IGFBP-3 differed also not betweenWLDs
and NWDs. IGF-1 serum levels are however lower in WLDs probably
due to the former obesity phenotype of these donors. On one hand, ex-
cessive growth and differentiation of stem and progenitor cells can be
deleterious due to accelerated exhaustion of stem cell niches, a hall-
mark of aging. On the contrary, excessive autophagy, a diminished
growth, differentiation and survival of these cells is a detrimental
factor for long-term maintenance of the organism, because of its del-
eterious effects on regeneration and renewal of tissues (Jones and Rando,
2011). For this reason, themaintenance of a correct balance between the
two situations could represent a crucial node in ASC homeostasis.
Hereby, we demonstrate a simultaneous up-regulation of IGF-1 and
DIRAS3 expression upon WL/CR in ASCs, in combination with reduced
insulin serum levels, and almost unaltered serum IGF-1 levels, which
supports the hypothesis that WL/CR optimizes the insulin/IGF-1–
mTOR signaling system in ASCs of sWAT, to achieve a protecting
resting-state. As a consequence, ASCs in sWAT of weight losing or calo-
rically restricted formerly obese individualswill present a higher renew-
al rate and readiness to grow and differentiate in permissive conditions.
This may contribute to maintenance of sWAT in conditions of CR, as
shown previously in mouse models (Huffman and Barzilai, 2010), and
contribute to postponement of sWAT aging.
Our ﬁndings contribute to a better understanding of the role of the
insulin/IGF-1 system in CR. In lower eukaryotes disruption of IGF-1/
insulin signaling increases lifespan (Kenyon, 2010; Johnson, 2013) and
knockouts of genes coding for several components of the GH/IGF-1–
mTOR signaling network extend lifespan in rodents (Coschigano et al.,
2000; Holzenberger et al., 2003, Taguchi et al., 2007; Selman et al.,
2009). Furthermore, CR induced longevity in rodents correlates with
decreased IGF-1 serum levels (Sonntag et al., 2012) and a decline in
the GH/IGF-1 axis in mice and humans is associated with decreased
incidence of cancer (Bartke et al., 2013). In contrast, reduced activity
of the IGF-1 pathway, which has diverse physiological functions, leads
often to detrimental effects. In fact, reduced IGF-1 serum levels correlate
with higher incidence of T2DM, cardiovascular diseases and declining
cognitive functions, suggesting that IGF-1 deﬁciency contributes to the
pathology of aging (Broughton and Partridge, 2009; Sonntag et al.,
2012). Supporting the notion, circulating IGF-1 levels decrease with
age in humans and animals and a reduction in serum IGF-1 levels
during aging impairs health span in mice (Gong et al., 2014). The
dual, beneﬁcial and deleterious actions of IGF-1 led to the current
concept, that IGF-1 signaling is a complex endocrine, paracrine and
autocrine network affecting organ development, homeostasis and
function throughout life (Broughton and Partridge, 2009; Sonntag
et al., 2012). Our study supports the hypothesis that the extent, tissue
and cell type speciﬁc IGF-1 activity are determinants of the effect on
health and lifespan.
IGF-1 is produced by the liver as endocrine hormone and in periph-
eral tissues in a paracrine/autocrine fashion. Adipose tissue contains
more IGF-1 than any other tissues except the liver (Stratikopoulos
et al., 2008). It is secreted inWAT in a GH-dependent and -independent
manner (Bartke et al., 2013) and by isolated ASCs and adipocytes
(Wabitsch et al., 2000; Poulos et al., 2010; this study). Supporting our
data that IGF-1 is highly expressed in ASCs of sWAT fromWLDs it was
demonstrated that IGF-1 levels are up-regulated in peripheral tissues
of Ames dwarf mice, which show the typical longevity phenotype of
chronically low IGF-1 serum levels (Bartke et al., 2013). In these mice,
local production of IGF-1 was demonstrated in the hippocampus (Sun
et al., 2005) correlating with neuroprotection (Schrag et al., 2008).
Moreover, signaling by insulin-like peptides (ILPs) is beneﬁcial in
neurons of ﬂies and worms, despite the paradox that lowered insulin/
IGF-1 activity has the potential to both compromise the integrity of
the CNS and extend lifespan (Broughton and Partridge, 2009). Further-
more, DR results in reduced expression of Drosophila ILP (DLIP) 5 in
neurosecretory cells in the brain. Deletion of the genes DILP 2, 3 and 5
in these cells, which extends lifespan, is however accompanied byup-regulation of DLIP 6 in the ﬂy fat body (Partridge et al., 2011).
Thus, similar to our ﬁndings in human ASCs, other studies show
increased IGF-1 levels in tissues of mammals and invertebrates in
response to either CR/DR or mutations reducing insulin/IGF-1 signaling,
which could reﬂect a compensatory response.
Long-livedmutant ﬂies with reduced DLIP signaling show increased
loss of germline stem cells (Hsu and Drummond-Barbosa, 2009) while
DR induces longevity and enhances germline stem cell maintenance in
ﬂies with age (Mair et al., 2010). The different mechanisms by which
these apparently related interventions have opposite effects on stem
cell maintenance are not precisely understood. Our data suggest that
WL/CR optimizes the activity of the IGF-1–mTOR systemwith beneﬁcial
effects on ASCs and sWAT homeostasis.
We demonstrated increased autophagy in sWAT of WLDs and
showed that negative regulation of Akt–mTOR signaling by DIRAS3 in
human ASCs increases autophagy, a hallmark of CR (de Cabo et al.,
2014). This establishes a mechanism how WL/CR employs IGF-1/
DIRAS3-mTOR signaling to induce autophagy. Increased autophagy
leads to higher turn-over of cellular material and recycles misfolded or
damaged cellular components. Thus, DIRAS3-induced autophagy in
ASCsmight facilitate homeostasis of cellularmacromolecules, providing
new cellular building blocks and energy for renewal and survival of
these cells. According to the currentmodel, nutrient overload in obesity
stimulates mTOR, thereby attenuating autophagy (Stienstra et al.,
2014). Increasing oxidative stress, hypoxia and inﬂammation induce
however insulin resistance in adipose tissues of obese people, leading
to inhibition of mTOR and consequently stimulation of autophagy.
Studies showing increased autophagy in adipose tissue of obese people
suggest that stimulatory effects for autophagy prevail over putative
inhibitory effects of mTORC1 activation by overeating (Stienstra et al.,
2014). Hereby, we have shown that activation of autophagy in sWAT
is a response to long-term WL/CR in formerly obese people. Thus,
autophagy in fat tissue is induced in both conditions, obesity and WL/
CR, and should affect adipose tissue mass and homeostasis; however,
most likely by different mechanisms and intensity.
We have shown that long-termWL/CRmodulates adipocyte differen-
tiation of ASCs in human sWAT by inducing both positive and negative
regulators of the IGF-1 system at early stages of adipogenesis. Important-
ly, we identiﬁed DIRAS3 as novel negative regulator of adipogenesis,
which slows down this process by inactivating Akt–mTOR signaling.
Congruent with our data, it was shown in other cell systems that
mTOR-induced adipogenesis is mediated partly by 4E-BP1 via regulation
of the translation of PPARγ2 and by S6K1, which regulates the expression
of early adipogenic transcription factors including C/EBPβ (Laplante and
Sabatini, 2012). Moreover, in line with data showing that activated ERK
can phosphorylate and thereby activate C/EBP-β (Park et al., 2004), we
showed that DIRAS3 inhibits ERK phosphorylation in ASCs and this corre-
lateswith reduced C/EBPβ activation. Pro-adipogenic effects of IGF-1have
been shown in previous studies (Bäck and Arnqvist, 2009; Boucher et al.,
2010). We extended this knowledge showing that IGF-1 can act as
positive regulator of adipogenesis in primary human ASCs and simulta-
neously induces IGF-1R and DIRAS3, indicating an interplay between
IGF-1 and DIRAS3 in modulating adipogenesis.
In conclusion, our results suggest that long-term WL-induced up-
regulation of DIRAS3 in ASCs in sWAT of formerly obese humans leads
to down-regulation of Akt–mTOR signaling in these cells. Moreover,
our data suggest that increased DIRAS3 levels in ASCs in sWAT of
WLDs contribute to the reduced adipogenic activity found in ASCs
explanted from sWAT of these donors. Furthermore, our ﬁndings
suggest that increased DIRAS3 levels activate autophagy in ASCs. This
study is at the interface between aging and obesity research. The trans-
lational value of the paper is in its contribution to a better understand-
ing of the molecular mechanisms underlying the effects of long-term
WL/CR on adipose tissue in formerly obese people.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2016.03.030.
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